Skip Nav Destination
Issues
June 2020
-
Cover Image
Cover Image
Cover: Colorful alley at night. Credit: Grandfailure. For more information, please visit istockphoto.com.
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
In This Issue
In This Issue of Diabetes Care
Diabetes Care May 2020, Vol.43, 1167-1168. doi:https://doi.org/10.2337/dc20-ti06
Commentaries
Glucose Variability and Diabetic Complications: Is It Time to Treat?
Diabetes Care May 2020, Vol.43, 1169-1171. doi:https://doi.org/10.2337/dci20-0012
Aging and Diabetes: Shifting the Risk Trajectory With High-Sensitivity Cardiac Troponins
Diabetes Care May 2020, Vol.43, 1172-1174. doi:https://doi.org/10.2337/dci20-0009
Clinical Care / Education / Nutrition / Psychosocial Research
Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes
Diabetes Care March 2020, Vol.43, 1178-1184. doi:https://doi.org/10.2337/dc19-2527
Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial
Chang-Sheng Sheng; Jingyan Tian; Ya Miao; Yi Cheng; Yulin Yang; Peter D. Reaven; Zachary T. Bloomgarden; Guang Ning
Diabetes Care March 2020, Vol.43, 1185-1190. doi:https://doi.org/10.2337/dc19-2589
Long-term Metabolic and Socioeducational Outcomes of Transient Neonatal Diabetes: A Longitudinal and Cross-sectional Study
Fleur Le Bourgeois; Jacques Beltrand; Baz Baz; Jean-Baptiste Julla; Jean-Pierre Riveline; Albane Simon; Isabelle Flechtner; Malek Ait Djoudi; Anne-Laure Fauret-Amsellem; Yoann Vial; Raphael Scharfmann; Julie Sommet; Philippe Boudou; Hélène Cavé; Michel Polak; Jean-François Gautier; Kanetee Busiah; TNDM Long-Term Follow-Up Study Group
Diabetes Care April 2020, Vol.43, 1191-1199. doi:https://doi.org/10.2337/dc19-0324
Epidemiology / Health Services Research
Performance of High-Sensitivity Cardiac Troponin Assays to Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes
Olive Tang; Natalie Daya; Kunihiro Matsushita; Josef Coresh; A. Richey Sharrett; Ron Hoogeveen; Xiaoming Jia; B. Gwen Windham; Christie Ballantyne; Elizabeth Selvin
Diabetes Care March 2020, Vol.43, 1200-1208. doi:https://doi.org/10.2337/dc19-2043
Sleep Duration Patterns in Early to Middle Adulthood and Subsequent Risk of Type 2 Diabetes in Women
Diabetes Care March 2020, Vol.43, 1219-1226. doi:https://doi.org/10.2337/dc19-2371
Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey
Diabetes Care March 2020, Vol.43, 1227-1233. doi:https://doi.org/10.2337/dc19-2424
Emerging Therapies: Drugs and Regimens
Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA1c, in Patients With Type 2 Diabetes
Ali Muhammed Ali; Robert Martinez; Hussein Al-Jobori; John Adams; Curtis Triplitt; Ralph DeFronzo; Eugenio Cersosimo; Muhammad Abdul-Ghani
Diabetes Care March 2020, Vol.43, 1234-1241. doi:https://doi.org/10.2337/dc18-2460
A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial
Francisco J. Pasquel; M. Cecilia Lansang; Ameer Khowaja; M. Agustina Urrutia; Saumeth Cardona; Bonnie Albury; Rodolfo J. Galindo; Maya Fayfman; Georgia Davis; Alexandra Migdal; Priyathama Vellanki; Limin Peng; Guillermo E. Umpierrez
Diabetes Care April 2020, Vol.43, 1242-1248. doi:https://doi.org/10.2337/dc19-1940
Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial
Hirotaka Watada; Akane Takami; Robert Spranger; Atsushi Amano; Yasuhiro Hashimoto; Elisabeth Niemoeller
Diabetes Care April 2020, Vol.43, 1249-1257. doi:https://doi.org/10.2337/dc19-2452
Pathophysiology / Complications
Circulating Retinol-Binding Protein 4 Is Inversely Associated With Pancreatic β-Cell Function Across the Spectrum of Glycemia
Diabetes Care April 2020, Vol.43, 1258-1265. doi:https://doi.org/10.2337/dc19-2432
Metabolic Factors, Lifestyle Habits, and Possible Polyneuropathy in Early Type 2 Diabetes: A Nationwide Study of 5,249 Patients in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Cohort
Diana H. Christensen; Søren T. Knudsen; Sandra S. Gylfadottir; Lotte B. Christensen; Jens S. Nielsen; Henning Beck-Nielsen; Henrik T. Sørensen; Henning Andersen; Brian C. Callaghan; Eva L. Feldman; Nanna B. Finnerup; Troels S. Jensen; Reimar W. Thomsen
Diabetes Care April 2020, Vol.43, 1266-1275. doi:https://doi.org/10.2337/dc19-2277
Cardiovascular and Metabolic Risk
Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits
Vasileios Liakopoulos; Stefan Franzén; Ann-Marie Svensson; Naveed Sattar; Mervete Miftaraj; Staffan Björck; Johan Ottosson; Ingmar Näslund; Soffia Gudbjörnsdottir; Björn Eliasson
Diabetes Care March 2020, Vol.43, 1276-1284. doi:https://doi.org/10.2337/dc19-1703
Reduced Myocardial Perfusion Reserve in Type 2 Diabetes Is Caused by Increased Perfusion at Rest and Decreased Maximal Perfusion During Stress
Martin H. Sørensen; Annemie S. Bojer; Julie R.N. Pontoppidan; David A. Broadbent; Sven Plein; Per L. Madsen; Peter Gæde
Diabetes Care March 2020, Vol.43, 1285-1292. doi:https://doi.org/10.2337/dc19-2172
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial
Jingyan Tian; Toshiaki Ohkuma; Mark Cooper; Stephen Harrap; Giuseppe Mancia; Neil Poulter; Ji-Guang Wang; Sophia Zoungas; Mark Woodward; John Chalmers
Diabetes Care March 2020, Vol.43, 1293-1299. doi:https://doi.org/10.2337/dc19-1817
Effects of Low-Energy Diet or Exercise on Cardiovascular Function in Working-Age Adults With Type 2 Diabetes: A Prospective, Randomized, Open-Label, Blinded End Point Trial
Gaurav S. Gulsin; Daniel J. Swarbrick; Lavanya Athithan; Emer M. Brady; Joseph Henson; Emma Baldry; Stavroula Argyridou; Nishal B. Jaicim; Gareth Squire; Yvette Walters; Anna-Marie Marsh; John McAdam; Kelly S. Parke; John D. Biglands; Thomas Yates; Kamlesh Khunti; Melanie J. Davies; Gerry P. McCann
Diabetes Care March 2020, Vol.43, 1300-1310. doi:https://doi.org/10.2337/dc20-0129
2017 American Academy of Pediatrics Clinical Practice Guideline: Impact on Prevalence of Arterial Hypertension in Children and Adolescents With Type 1 Diabetes
Axel Dost; Susanne Bechtold; Katharina Fink; Walter Bonfig; Dagobert Wiemann; Thomas M. Kapellen; Michael Witsch; Karl O. Schwab; Reinhard W. Holl; for the initiative DPV-Science and the German Diabetes Research Center
Diabetes Care March 2020, Vol.43, 1311-1318. doi:https://doi.org/10.2337/dc19-2022
Microbiota-Related Metabolites and the Risk of Type 2 Diabetes
Diabetes Care April 2020, Vol.43, 1319-1325. doi:https://doi.org/10.2337/dc19-2533
Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study
Björn Pasternak; Viktor Wintzell; Björn Eliasson; Ann-Marie Svensson; Stefan Franzén; Soffia Gudbjörnsdottir; Kristian Hveem; Christian Jonasson; Mads Melbye; Henrik Svanström; Peter Ueda
Diabetes Care April 2020, Vol.43, 1326-1335. doi:https://doi.org/10.2337/dc19-2088
Decreased Vagal Activity and Deviation in Sympathetic Activity Precedes Development of Diabetes
Da Young Lee; Mi Yeon Lee; Jung Hwan Cho; Hyemi Kwon; Eun-Jung Rhee; Cheol-Young Park; Ki-Won Oh; Won-Young Lee; Sung-Woo Park; Seungho Ryu; Se Eun Park
Diabetes Care April 2020, Vol.43, 1336-1343. doi:https://doi.org/10.2337/dc19-1384
Dietary Manganese, Plasma Markers of Inflammation, and the Development of Type 2 Diabetes in Postmenopausal Women: Findings From the Women’s Health Initiative
Jung Ho Gong; Kenneth Lo; Qing Liu; Jie Li; Shuiqing Lai; Aladdin H. Shadyab; Chrisa Arcan; Linda Snetselaar; Simin Liu
Diabetes Care April 2020, Vol.43, 1344-1351. doi:https://doi.org/10.2337/dc20-0243
Novel Communications in Diabetes
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
Mark L. Hartman; Arun J. Sanyal; Rohit Loomba; Jonathan M. Wilson; Amir Nikooienejad; Ross Bray; Chrisanthi A. Karanikas; Kevin L. Duffin; Deborah A. Robins; Axel Haupt
Diabetes Care April 2020, Vol.43, 1352-1355. doi:https://doi.org/10.2337/dc19-1892
Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial
Jagdeep S.S. Singh; Ify R. Mordi; Keeran Vickneson; Amir Fathi; Peter T. Donnan; Mohapradeep Mohan; Anna Maria J. Choy; Stephen Gandy; Jacob George; Faisel Khan; Ewan R. Pearson; J. Graeme Houston; Allan D. Struthers; Chim C. Lang
Diabetes Care April 2020, Vol.43, 1356-1359. doi:https://doi.org/10.2337/dc19-2187
Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S.
Timothy J. Garrett; Philip Atkinson; Eoin P. Quinlivan; Lynn Ang; Irl B. Hirsch; Lori Laffel; Massimo Pietropaolo; Michael J. Haller; Mark A. Atkinson
Diabetes Care April 2020, Vol.43, 1360-1362. doi:https://doi.org/10.2337/dc19-1941
Wilson Disease With Novel Compound Heterozygote Mutations in the ATP7B Gene Presenting With Severe Diabetes
Juyi Li; Yanli Jiang; Teng Xu; Yao Zhang; Jiajia Xue; Xiao Gao; Xiaoyan Yang; Xiufang Wang; Xiong Jia; Wenzhuo Cheng; Si Jin
Diabetes Care April 2020, Vol.43, 1363-1365. doi:https://doi.org/10.2337/dc19-2033
Errata
Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607–615
Boris Kovatchev; Stacey M. Anderson; Dan Raghinaru; Yogish C. Kudva; Lori M. Laffel; Carol Levy; Jordan E. Pinsker; R. Paul Wadwa; Bruce Buckingham; Francis J. Doyle, III; Sue A. Brown; Mei Mei Church; Vikash Dadlani; Eyal Dassau; Laya Ekhlaspour; Gregory P. Forlenza; Elvira Isganaitis; David W. Lam; John Lum; Roy W. Beck; for the iDCL Study Group
Diabetes Care April 2020, Vol.43, 1366. doi:https://doi.org/10.2337/dc20-er06
Erratum. Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach. Diabetes Care 2020;43:852–859
Ali Aminian; Alexander Zajichek; David E. Arterburn; Kathy E. Wolski; Stacy A. Brethauer; Philip R. Schauer; Steven E. Nissen; Michael W. Kattan
Diabetes Care April 2020, Vol.43, 1367. doi:https://doi.org/10.2337/dc20-er06a
Issues and Events
e-Letters
Observations
Incidence of Type 2 Diabetes in Patients With Chronic Hepatitis C Receiving Interferon-Based Therapy
Ming-Chieh Tsai; Kai-Liang Kao; Hui-Chun Huang; Weishan Chen; Chun-Kai Fang; Fung-Chang Sung; Shu-I Wu; Robert Stewart
Diabetes Care March 2020, Vol.43, e63-e64. doi:https://doi.org/10.2337/dc19-1704
Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY
Diabetes Care April 2020, Vol.43, e65. doi:https://doi.org/10.2337/dc20-0012
Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes
Diabetes Care April 2020, Vol.43, e66-e67. doi:https://doi.org/10.2337/dc19-2426
Comments and Responses
Comment on Lee et al. The Impact of Medicaid Expansion on Diabetes Management. Diabetes Care 2020;43:1094–1101
Diabetes Care May 2020, Vol.43, e70. doi:https://doi.org/10.2337/dc19-2485
Response to Comment on Lee et al. The Impact of Medicaid Expansion on Diabetes Management. Diabetes Care 2020;43:1094–1101
Diabetes Care May 2020, Vol.43, e71. doi:https://doi.org/10.2337/dci20-0007
